Sight Sciences Inc SGHT.OQ SGHT.O is expected to show a fall in quarterly revenue when it reports results on August 7 for the period ending June 30 2025
The Menlo Park California-based company is expected to report a 14.9% decrease in revenue to $18.183 million from $21.37 million a year ago, according to the mean estimate from 6 analysts, based on LSEG data.
LSEG's mean analyst estimate for Sight Sciences Inc is for a loss of 26 cents per share.
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," 5 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Sight Sciences Inc is $4.00, about 12.7% above its last closing price of $3.49
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2025 | -0.27 | -0.28 | -0.28 | Met | 0.8 |
Dec. 31 2025 | -0.21 | -0.20 | -0.23 | Missed | -13 |
Sep. 30 2024 | -0.22 | -0.21 | -0.22 | Missed | -6 |
Jun. 30 2024 | -0.30 | -0.30 | -0.25 | Beat | 15.5 |
Mar. 31 2024 | -0.26 | -0.28 | -0.33 | Missed | -19.7 |
Dec. 31 2023 | -0.30 | -0.32 | -0.22 | Beat | 30.6 |
Sep. 30 2023 | -0.31 | -0.32 | -0.27 | Beat | 15 |
Jun. 30 2023 | -0.34 | -0.34 | -0.30 | Beat | 12.1 |
This summary was machine generated August 5 at 23:20 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)